[1]
“Antibody-drug conjugates in the treatment of breast cancer: advances, limitations, and future perspectives – a literature review”, IJAMB, vol. 8, no. 1, p. e150, Jul. 2026, doi: 10.52466/ijamb.v8i1.150.